Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.

NCT02334709 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Ghent